|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:XRCC5-TRIM22 (FusionGDB2 ID:99095) |
Fusion Gene Summary for XRCC5-TRIM22 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: XRCC5-TRIM22 | Fusion gene ID: 99095 | Hgene | Tgene | Gene symbol | XRCC5 | TRIM22 | Gene ID | 7520 | 10346 |
| Gene name | X-ray repair cross complementing 5 | tripartite motif containing 22 | |
| Synonyms | KARP-1|KARP1|KU80|KUB2|Ku86|NFIV | GPSTAF50|RNF94|STAF50 | |
| Cytomap | 2q35 | 11p15.4 | |
| Type of gene | protein-coding | protein-coding | |
| Description | X-ray repair cross-complementing protein 586 kDa subunit of Ku antigenATP-dependent DNA helicase 2 subunit 2ATP-dependent DNA helicase II 80 kDa subunitCTC box-binding factor 85 kDa subunitCTC85CTCBFDNA repair protein XRCC5Ku autoantigen, 80kDaKu | E3 ubiquitin-protein ligase TRIM2250 kDa-stimulated trans-acting factorRING finger protein 94RING-type E3 ubiquitin transferase TRIM22staf-50stimulated trans-acting factor (50 kDa)tripartite binding motif 22tripartite motif protein TRIM22tripartit | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | . | . | |
| Ensembl transtripts involved in fusion gene | ENST00000392133, ENST00000392132, ENST00000471649, | ENST00000379965, | |
| Fusion gene scores | * DoF score | 13 X 10 X 7=910 | 7 X 5 X 4=140 |
| # samples | 12 | 6 | |
| ** MAII score | log2(12/910*10)=-2.92283213947754 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/140*10)=-1.22239242133645 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: XRCC5 [Title/Abstract] AND TRIM22 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | XRCC5(216974180)-TRIM22(5719545), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | XRCC5 | GO:0002218 | activation of innate immune response | 28712728 |
| Hgene | XRCC5 | GO:0006303 | double-strand break repair via nonhomologous end joining | 26359349 |
| Hgene | XRCC5 | GO:0045860 | positive regulation of protein kinase activity | 22504299 |
| Hgene | XRCC5 | GO:0071480 | cellular response to gamma radiation | 26359349 |
| Tgene | TRIM22 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 23077300 |
| Tgene | TRIM22 | GO:0051091 | positive regulation of DNA-binding transcription factor activity | 23077300 |
| Tgene | TRIM22 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 23077300 |
| Fusion gene breakpoints across XRCC5 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across TRIM22 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | STAD | TCGA-BR-A4PE-01A | XRCC5 | chr2 | 216974180 | + | TRIM22 | chr11 | 5719545 | + |
Top |
Fusion Gene ORF analysis for XRCC5-TRIM22 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000392133 | ENST00000379965 | XRCC5 | chr2 | 216974180 | + | TRIM22 | chr11 | 5719545 | + |
| In-frame | ENST00000392132 | ENST00000379965 | XRCC5 | chr2 | 216974180 | + | TRIM22 | chr11 | 5719545 | + |
| intron-3CDS | ENST00000471649 | ENST00000379965 | XRCC5 | chr2 | 216974180 | + | TRIM22 | chr11 | 5719545 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000392133 | XRCC5 | chr2 | 216974180 | + | ENST00000379965 | TRIM22 | chr11 | 5719545 | + | 2675 | 482 | 71 | 1459 | 462 |
| ENST00000392132 | XRCC5 | chr2 | 216974180 | + | ENST00000379965 | TRIM22 | chr11 | 5719545 | + | 2354 | 161 | 56 | 1138 | 360 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000392133 | ENST00000379965 | XRCC5 | chr2 | 216974180 | + | TRIM22 | chr11 | 5719545 | + | 0.000647694 | 0.9993523 |
| ENST00000392132 | ENST00000379965 | XRCC5 | chr2 | 216974180 | + | TRIM22 | chr11 | 5719545 | + | 0.000688842 | 0.9993112 |
Top |
Fusion Genomic Features for XRCC5-TRIM22 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| XRCC5 | chr2 | 216974180 | + | TRIM22 | chr11 | 5719544 | + | 7.23E-05 | 0.99992764 |
| XRCC5 | chr2 | 216974180 | + | TRIM22 | chr11 | 5719544 | + | 7.23E-05 | 0.99992764 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for XRCC5-TRIM22 |
| Go to FGviewer for the breakpoints of chr2:216974180-chr11:5719545 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | . |
| FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | TRIM22 | chr2:216974180 | chr11:5719545 | ENST00000379965 | 2 | 8 | 283_498 | 173.0 | 499.0 | Domain | B30.2/SPRY | |
| Tgene | TRIM22 | chr2:216974180 | chr11:5719545 | ENST00000379965 | 2 | 8 | 257_275 | 173.0 | 499.0 | Motif | Nuclear localization signal |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | XRCC5 | chr2:216974180 | chr11:5719545 | ENST00000392132 | + | 1 | 21 | 478_519 | 7.0 | 733.0 | Compositional bias | Note=Pro-rich |
| Hgene | XRCC5 | chr2:216974180 | chr11:5719545 | ENST00000392133 | + | 3 | 23 | 478_519 | 7.0 | 733.0 | Compositional bias | Note=Pro-rich |
| Hgene | XRCC5 | chr2:216974180 | chr11:5719545 | ENST00000392132 | + | 1 | 21 | 251_460 | 7.0 | 733.0 | Domain | Note=Ku |
| Hgene | XRCC5 | chr2:216974180 | chr11:5719545 | ENST00000392133 | + | 3 | 23 | 251_460 | 7.0 | 733.0 | Domain | Note=Ku |
| Hgene | XRCC5 | chr2:216974180 | chr11:5719545 | ENST00000392132 | + | 1 | 21 | 720_728 | 7.0 | 733.0 | Motif | Note=EEXXXDL motif |
| Hgene | XRCC5 | chr2:216974180 | chr11:5719545 | ENST00000392133 | + | 3 | 23 | 720_728 | 7.0 | 733.0 | Motif | Note=EEXXXDL motif |
| Hgene | XRCC5 | chr2:216974180 | chr11:5719545 | ENST00000392132 | + | 1 | 21 | 138_165 | 7.0 | 733.0 | Region | Note=Leucine-zipper |
| Hgene | XRCC5 | chr2:216974180 | chr11:5719545 | ENST00000392133 | + | 3 | 23 | 138_165 | 7.0 | 733.0 | Region | Note=Leucine-zipper |
| Tgene | TRIM22 | chr2:216974180 | chr11:5719545 | ENST00000379965 | 2 | 8 | 132_248 | 173.0 | 499.0 | Coiled coil | Ontology_term=ECO:0000255 | |
| Tgene | TRIM22 | chr2:216974180 | chr11:5719545 | ENST00000379965 | 2 | 8 | 15_60 | 173.0 | 499.0 | Zinc finger | RING-type | |
| Tgene | TRIM22 | chr2:216974180 | chr11:5719545 | ENST00000379965 | 2 | 8 | 92_133 | 173.0 | 499.0 | Zinc finger | B box-type |
Top |
Fusion Gene Sequence for XRCC5-TRIM22 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000392133_ENST00000379965_TCGA-BR-A4PE-01A_XRCC5_chr2_216974180_+_TRIM22_chr11_5719545_length(transcript)=2675nt_BP=482nt AGAAACCCCACAAAAATTAGCTGGGCTTGGTGGCACACACCTGTGGTCCCAGCTACCTGGGAGGCTGAGCTCTGGATCGTACAAGAAGGG AGACAAGGACCACTGACAAGATATGCGTTTCAGGCGGCTCAAACACCACACGCTCCCGACTACGGCGGAATGGAGAGAATGTGCGCATGC TCGGCGGGAATCTGCGCATGCTCGGCGGGAATCTGCGCATGCTCGGAGAGAATCTGCGCATGCTCGGCCGGAATCTGCGCGAGCTCGGCG GGAATCTGCGCAAGCTCGGCGGGAATCTGCGCATGCTCAGAGTTCCGGGGCACGGTTTCCCCGCCCCTTTCAGGCCTAGCAGGAAACGAA GCGGCTCTTTCCGCTATCTGCCGCTTGTCCACCGGAAGCGAGTTGCGACACGGCAGGTTCCCGCCCGGAAGAAGCGACCAAAGCGCCTGA GGACCGGCAACATGGTGCGGTCGGGGAATAAGAATTATATCCAGATCGAGAGACAGAAGATTCTGAAAGGGTTCAATGAAATGAGAGTCA TCTTGGACAATGAGGAGCAGAGAGAGCTGCAAAAGCTGGAGGAAGGTGAGGTGAATGTGCTGGATAACCTGGCAGCAGCTACAGACCAGC TGGTCCAGCAGAGGCAGGATGCCAGCACGCTCATCTCAGATCTCCAGCGGAGGTTGAGGGGATCGTCAGTAGAGATGCTGCAGGATGTGA TTGACGTCATGAAAAGGAGTGAAAGCTGGACATTGAAGAAGCCAAAATCTGTTTCCAAGAAACTAAAGAGTGTATTCCGAGTACCAGATC TGAGTGGGATGCTGCAAGTTCTTAAAGAGCTGACAGATGTCCAGTACTACTGGGTGGACGTGATGCTGAATCCAGGCAGTGCCACTTCGA ATGTTGCTATTTCTGTGGATCAGAGACAAGTGAAAACTGTACGCACCTGCACATTTAAGAATTCAAATCCATGTGATTTTTCTGCTTTTG GTGTCTTCGGCTGCCAATATTTCTCTTCGGGGAAATATTACTGGGAAGTAGATGTGTCTGGAAAGATTGCCTGGATCCTGGGCGTACACA GTAAAATAAGTAGTCTGAATAAAAGGAAGAGCTCTGGGTTTGCTTTTGATCCAAGTGTAAATTATTCAAAAGTTTACTCCAGATATAGAC CTCAATATGGCTACTGGGTTATAGGATTACAGAATACATGTGAATATAATGCTTTTGAGGACTCCTCCTCTTCTGATCCCAAGGTTTTGA CTCTCTTTATGGCTGTGCCTCCCTGTCGTATTGGGGTTTTCCTAGACTATGAGGCAGGCATTGTCTCATTTTTCAATGTCACAAACCACG GAGCACTCATCTACAAGTTCTCTGGATGTCGCTTTTCTCGACCTGCTTATCCGTATTTCAATCCTTGGAACTGCCTAGTCCCCATGACTG TGTGCCCACCGAGCTCCTGAGTGTTCTCATTCCTTTACCCACTTCTGCATAGTAGCCCTTGTGCTGAGACTCAGATTCTGCACCTGAGTT CATCTCTACTGAGACCATCTCTTCCTTTCTTTCCCCTTCTTTTACTTAGAATGTCTTTGTATTCATTTGCTAGGGCTTCCATAGCAAAGC ATCATAGATTGCTGATTTAAACTGTAATTGTATTGCCGTACTGTGGGCTGGAAATCCCAAATCTAGATTCCAGCAGAGTTGGTTCTTTCT GAGGTCTGCAAGGAAGGGCTCTGTTCCATGCCTCTCTCCTTGGCTTGTAGAAGGCATCTTGTCCCTATGACTCTTCACATTGTCTTTATG TACATCTCTGTGCCCAAGTTTTCCCTTTTTATTAAGACACCAGTCATACTGGCTCAGGGCCCACCGCTAATGCCTTAATGAAATCATTTT AACATTATATTCTCTACAAAGACCTTATTTCCAAATAAGATAATATTTGGAGGTATTGGGAATAAAAACTCCAACATATAAATTTGAGGA AGGCACGATTTCACTCATAACAATCTTACCCTTTCTTGCAAGAGATGCTTGTACATTATTTTCCTAATACCTTGGTTTCACTAGTAGTAA ACATTATTATTTTTTTTATATTTGCAAAGGAAACATATCTAATCCTTCCTATAGAAAGAACAGTATTGCTGTAATTCCTTTTCTTTTCTT CCTCATTTCCTCTGCCCCTTAAAAGATTGAAGAAAGAGAAACTTGTCAACTCATATCCACGTTATCTAGCAAAGTACATAAGAATCTATC ACTAAGTAATGTATCCTTCAGAATGTGTTGGTTTACCAGTGACACCCCATATTCATCACAAAATTAAAGCAAGAAGTCCATAGTAATTTA TTTGCTAATAGTGGATTTTTAATGCTCAGAGTTTCTGAGGTCAAATTTTATCTTTTCACTTACAAGCTCTATGATCTTAAATAATTTACT TAATGTATTTTGGTGTATTTTCCTCAAATTAATATTGGTGTTCAAGACTATATCTAATTCCTCTGATCACTTTGAGAAACAAACTTTTAT TAAATGTAAGGCACTTTTCTATGAATTTTAAATATAAAAATAAATATTGTTCTGATTATTACTGAAAAGATGTCAGCCATTTCAATGTCT >In-frame_ENST00000392133_ENST00000379965_TCGA-BR-A4PE-01A_XRCC5_chr2_216974180_+_TRIM22_chr11_5719545_length(amino acids)=462AA_start in transcript=71_stop in transcript=1459 MDRTRRETRTTDKICVSGGSNTTRSRLRRNGENVRMLGGNLRMLGGNLRMLGENLRMLGRNLRELGGNLRKLGGNLRMLRVPGHGFPAPF RPSRKRSGSFRYLPLVHRKRVATRQVPARKKRPKRLRTGNMVRSGNKNYIQIERQKILKGFNEMRVILDNEEQRELQKLEEGEVNVLDNL AAATDQLVQQRQDASTLISDLQRRLRGSSVEMLQDVIDVMKRSESWTLKKPKSVSKKLKSVFRVPDLSGMLQVLKELTDVQYYWVDVMLN PGSATSNVAISVDQRQVKTVRTCTFKNSNPCDFSAFGVFGCQYFSSGKYYWEVDVSGKIAWILGVHSKISSLNKRKSSGFAFDPSVNYSK VYSRYRPQYGYWVIGLQNTCEYNAFEDSSSSDPKVLTLFMAVPPCRIGVFLDYEAGIVSFFNVTNHGALIYKFSGCRFSRPAYPYFNPWN -------------------------------------------------------------- >In-frame_ENST00000392132_ENST00000379965_TCGA-BR-A4PE-01A_XRCC5_chr2_216974180_+_TRIM22_chr11_5719545_length(transcript)=2354nt_BP=161nt ACGGTTTCCCCGCCCCTTTCAGGCCTAGCAGGAAACGAAGCGGCTCTTTCCGCTATCTGCCGCTTGTCCACCGGAAGCGAGTTGCGACAC GGCAGGTTCCCGCCCGGAAGAAGCGACCAAAGCGCCTGAGGACCGGCAACATGGTGCGGTCGGGGAATAAGAATTATATCCAGATCGAGA GACAGAAGATTCTGAAAGGGTTCAATGAAATGAGAGTCATCTTGGACAATGAGGAGCAGAGAGAGCTGCAAAAGCTGGAGGAAGGTGAGG TGAATGTGCTGGATAACCTGGCAGCAGCTACAGACCAGCTGGTCCAGCAGAGGCAGGATGCCAGCACGCTCATCTCAGATCTCCAGCGGA GGTTGAGGGGATCGTCAGTAGAGATGCTGCAGGATGTGATTGACGTCATGAAAAGGAGTGAAAGCTGGACATTGAAGAAGCCAAAATCTG TTTCCAAGAAACTAAAGAGTGTATTCCGAGTACCAGATCTGAGTGGGATGCTGCAAGTTCTTAAAGAGCTGACAGATGTCCAGTACTACT GGGTGGACGTGATGCTGAATCCAGGCAGTGCCACTTCGAATGTTGCTATTTCTGTGGATCAGAGACAAGTGAAAACTGTACGCACCTGCA CATTTAAGAATTCAAATCCATGTGATTTTTCTGCTTTTGGTGTCTTCGGCTGCCAATATTTCTCTTCGGGGAAATATTACTGGGAAGTAG ATGTGTCTGGAAAGATTGCCTGGATCCTGGGCGTACACAGTAAAATAAGTAGTCTGAATAAAAGGAAGAGCTCTGGGTTTGCTTTTGATC CAAGTGTAAATTATTCAAAAGTTTACTCCAGATATAGACCTCAATATGGCTACTGGGTTATAGGATTACAGAATACATGTGAATATAATG CTTTTGAGGACTCCTCCTCTTCTGATCCCAAGGTTTTGACTCTCTTTATGGCTGTGCCTCCCTGTCGTATTGGGGTTTTCCTAGACTATG AGGCAGGCATTGTCTCATTTTTCAATGTCACAAACCACGGAGCACTCATCTACAAGTTCTCTGGATGTCGCTTTTCTCGACCTGCTTATC CGTATTTCAATCCTTGGAACTGCCTAGTCCCCATGACTGTGTGCCCACCGAGCTCCTGAGTGTTCTCATTCCTTTACCCACTTCTGCATA GTAGCCCTTGTGCTGAGACTCAGATTCTGCACCTGAGTTCATCTCTACTGAGACCATCTCTTCCTTTCTTTCCCCTTCTTTTACTTAGAA TGTCTTTGTATTCATTTGCTAGGGCTTCCATAGCAAAGCATCATAGATTGCTGATTTAAACTGTAATTGTATTGCCGTACTGTGGGCTGG AAATCCCAAATCTAGATTCCAGCAGAGTTGGTTCTTTCTGAGGTCTGCAAGGAAGGGCTCTGTTCCATGCCTCTCTCCTTGGCTTGTAGA AGGCATCTTGTCCCTATGACTCTTCACATTGTCTTTATGTACATCTCTGTGCCCAAGTTTTCCCTTTTTATTAAGACACCAGTCATACTG GCTCAGGGCCCACCGCTAATGCCTTAATGAAATCATTTTAACATTATATTCTCTACAAAGACCTTATTTCCAAATAAGATAATATTTGGA GGTATTGGGAATAAAAACTCCAACATATAAATTTGAGGAAGGCACGATTTCACTCATAACAATCTTACCCTTTCTTGCAAGAGATGCTTG TACATTATTTTCCTAATACCTTGGTTTCACTAGTAGTAAACATTATTATTTTTTTTATATTTGCAAAGGAAACATATCTAATCCTTCCTA TAGAAAGAACAGTATTGCTGTAATTCCTTTTCTTTTCTTCCTCATTTCCTCTGCCCCTTAAAAGATTGAAGAAAGAGAAACTTGTCAACT CATATCCACGTTATCTAGCAAAGTACATAAGAATCTATCACTAAGTAATGTATCCTTCAGAATGTGTTGGTTTACCAGTGACACCCCATA TTCATCACAAAATTAAAGCAAGAAGTCCATAGTAATTTATTTGCTAATAGTGGATTTTTAATGCTCAGAGTTTCTGAGGTCAAATTTTAT CTTTTCACTTACAAGCTCTATGATCTTAAATAATTTACTTAATGTATTTTGGTGTATTTTCCTCAAATTAATATTGGTGTTCAAGACTAT ATCTAATTCCTCTGATCACTTTGAGAAACAAACTTTTATTAAATGTAAGGCACTTTTCTATGAATTTTAAATATAAAAATAAATATTGTT CTGATTATTACTGAAAAGATGTCAGCCATTTCAATGTCTTGGGAAACAATTTTTTGTTTTTGTTCTGTTTTCTTTTTGCTTCAATAAAAC >In-frame_ENST00000392132_ENST00000379965_TCGA-BR-A4PE-01A_XRCC5_chr2_216974180_+_TRIM22_chr11_5719545_length(amino acids)=360AA_start in transcript=56_stop in transcript=1138 MPLVHRKRVATRQVPARKKRPKRLRTGNMVRSGNKNYIQIERQKILKGFNEMRVILDNEEQRELQKLEEGEVNVLDNLAAATDQLVQQRQ DASTLISDLQRRLRGSSVEMLQDVIDVMKRSESWTLKKPKSVSKKLKSVFRVPDLSGMLQVLKELTDVQYYWVDVMLNPGSATSNVAISV DQRQVKTVRTCTFKNSNPCDFSAFGVFGCQYFSSGKYYWEVDVSGKIAWILGVHSKISSLNKRKSSGFAFDPSVNYSKVYSRYRPQYGYW VIGLQNTCEYNAFEDSSSSDPKVLTLFMAVPPCRIGVFLDYEAGIVSFFNVTNHGALIYKFSGCRFSRPAYPYFNPWNCLVPMTVCPPSS -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for XRCC5-TRIM22 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for XRCC5-TRIM22 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for XRCC5-TRIM22 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | XRCC5 | C0001973 | Alcoholic Intoxication, Chronic | 1 | PSYGENET |
| Hgene | XRCC5 | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
| Hgene | XRCC5 | C0678306 | alcohol sensitivity | 1 | PSYGENET |
| Tgene | TRIM22 | C0021400 | Influenza | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies